{"id":"steroid-eye-drops","safety":{"commonSideEffects":[{"rate":null,"effect":"Elevated intraocular pressure"},{"rate":null,"effect":"Cataract formation (with prolonged use)"},{"rate":null,"effect":"Local irritation or discomfort"},{"rate":null,"effect":"Secondary infection risk"}]},"_chembl":{"chemblId":"CHEMBL98374","moleculeType":"Small molecule","molecularWeight":"310.44"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Topical corticosteroids reduce inflammation in the eye by suppressing immune cell activation, decreasing cytokine and prostaglandin production, and stabilizing the blood-ocular barrier. This mechanism provides rapid anti-inflammatory and immunosuppressive effects in ocular tissues, making them effective for inflammatory eye conditions. The Phase 3 formulation from Radboud University likely represents an optimized delivery or novel steroid compound for improved efficacy or safety in ocular use.","oneSentence":"Steroid eye drops suppress local ocular inflammation by binding to glucocorticoid receptors and inhibiting inflammatory mediator production.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:36:33.157Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Ocular inflammation (post-operative or allergic)"},{"name":"Anterior uveitis"},{"name":"Corneal inflammation"}]},"trialDetails":[{"nctId":"NCT07496060","phase":"PHASE4","title":"Loteprednol Etabonate Versus Prednisolone Acetate for Anterior Chamber Granulomas","status":"COMPLETED","sponsor":"Fayoum University","startDate":"2025-08-10","conditions":"Anterior Chamber Granulomatous Uveitis","enrollment":66},{"nctId":"NCT06365853","phase":"PHASE2","title":"A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression","status":"RECRUITING","sponsor":"AbbVie","startDate":"2024-07-29","conditions":"Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive","enrollment":100},{"nctId":"NCT04149210","phase":"PHASE3","title":"FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial","status":"COMPLETED","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2021-08-19","conditions":"Trachomatous Trichiasis (TT), Eye Diseases, Eyelid Diseases","enrollment":2410},{"nctId":"NCT06235567","phase":"PHASE1, PHASE2","title":"Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal Crosslinking","status":"ENROLLING_BY_INVITATION","sponsor":"Maanasa Indaram, MD","startDate":"2025-04-11","conditions":"Keratoconus","enrollment":20},{"nctId":"NCT05319730","phase":"PHASE1, PHASE2","title":"A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-05-16","conditions":"Esophageal Squamous Cell Carcinoma","enrollment":230},{"nctId":"NCT07457216","phase":"NA","title":"Visual and Patient-Reported Outcomes After Bilateral Non-Diffractive EDOF IOL Implantation","status":"COMPLETED","sponsor":"Benha University","startDate":"2025-01-03","conditions":"Extended Depth-of-Focus Intraocular Lens, Cataract, Visual Acuity","enrollment":30},{"nctId":"NCT05626478","phase":"PHASE4","title":"Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery","status":"COMPLETED","sponsor":"Nicole Fram M.D.","startDate":"2023-06-01","conditions":"Corneal Edema, Corneal Defect, Anterior Chamber Inflammation","enrollment":50},{"nctId":"NCT06637423","phase":"PHASE1, PHASE2","title":"A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-12-20","conditions":"Non-Muscle Invasive Bladder Cancer","enrollment":32},{"nctId":"NCT04371445","phase":"PHASE4","title":"Dextenza in the Post-op Management of Vitreoretinal Surgeries","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2020-06-01","conditions":"Vitreoretinal Surgery, Ocular Inflammation, Post-operative Pain","enrollment":30},{"nctId":"NCT06213649","phase":"PHASE3","title":"Parasitic Ulcer Treatment Trial","status":"RECRUITING","sponsor":"Jeremy Keenan, MD, MPH","startDate":"2024-07-01","conditions":"Acanthamoeba Keratitis","enrollment":232},{"nctId":"NCT06428409","phase":"PHASE1, PHASE2","title":"A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-06-20","conditions":"Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer","enrollment":220},{"nctId":"NCT05066997","phase":"PHASE2, PHASE3","title":"A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Oculis","startDate":"2021-10-19","conditions":"Diabetic Macular Edema","enrollment":552},{"nctId":"NCT06172257","phase":"PHASE3","title":"A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Oculis","startDate":"2024-03-15","conditions":"Diabetic Macular Edema","enrollment":401},{"nctId":"NCT06271772","phase":"PHASE3","title":"Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-07-01","conditions":"Bacterial Keratitis","enrollment":60},{"nctId":"NCT03933631","phase":"PHASE3","title":"Pilocarpine Use After Kahook Goniotomy","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2019-05-01","conditions":"Glaucoma","enrollment":142},{"nctId":"NCT05542381","phase":"NA","title":"The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain","status":"COMPLETED","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2022-12-22","conditions":"Age-Related Macular Degeneration","enrollment":64},{"nctId":"NCT07138742","phase":"NA","title":"Tacrolimus Eye Drops in Treatment of Vernal Keratoconjunctivitis","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2025-09","conditions":"Vernal Keratoconjunctivitis","enrollment":90},{"nctId":"NCT05620901","phase":"EARLY_PHASE1","title":"DEXTENZA in Pediatric Patients Following Retinal Surgery or Laser Treatment Under Anesthesia","status":"COMPLETED","sponsor":"Lejla Vajzovic, MD, FASRS","startDate":"2023-02-01","conditions":"Vitreoretinopathy, Coats' Disease, Exudative Retinopathy","enrollment":16},{"nctId":"NCT05668455","phase":"PHASE3","title":"Comparison of Topical Treatment for Inflammatory Secretions of the Conjonctiva (Patients With Ocular Prostheses)","status":"RECRUITING","sponsor":"Agnes","startDate":"2023-05-12","conditions":"Ocular Inflammation, Ocular Prostheses","enrollment":30},{"nctId":"NCT03324113","phase":"PHASE1","title":"Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors","status":"COMPLETED","sponsor":"Sanofi","startDate":"2017-10-17","conditions":"Neoplasm Malignant","enrollment":34},{"nctId":"NCT07090044","phase":"PHASE4","title":"Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period","status":"COMPLETED","sponsor":"Retina Research Institute, LLC","startDate":"2021-08-20","conditions":"Vein Occlusion, Macular Degeneration Choroidal Neovascularization, Macular Edema","enrollment":77},{"nctId":"NCT05331664","phase":"PHASE4","title":"Dropless Pars Plana Vitrectomy Study","status":"RECRUITING","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2022-07-25","conditions":"Rhegmatogenous Retinal Detachment","enrollment":168},{"nctId":"NCT03317847","phase":"PHASE4","title":"Bromfenac Versus Dexamethasone After Cataract Surgery","status":"COMPLETED","sponsor":"Azienda USL Reggio Emilia - IRCCS","startDate":"2017-10-16","conditions":"Inflammation Eye","enrollment":92},{"nctId":"NCT02137161","phase":"PHASE4","title":"Bromfenac to Reduce Inflammation in Patients With Pseudoexfoliation Syndrome After Cataract Surgery","status":"COMPLETED","sponsor":"Azienda USL Reggio Emilia - IRCCS","startDate":"2013-11","conditions":"Cataract, Pseudoexfoliation Syndrome","enrollment":62},{"nctId":"NCT06785090","phase":"PHASE4","title":"Effects of Bromfenac on Macular Thickness After Phacoemulsification Surgery","status":"COMPLETED","sponsor":"Inas Abd","startDate":"2023-05-01","conditions":"Cataract, Cystoid Macular Edema After Phacoemulsification","enrollment":87},{"nctId":"NCT04418999","phase":"EARLY_PHASE1","title":"Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus","status":"COMPLETED","sponsor":"Illinois College of Optometry","startDate":"2020-09-01","conditions":"Keratoconus, Dry Eye, Allergy","enrollment":36},{"nctId":"NCT06876116","phase":"PHASE4","title":"Once-daily Fluorometholone vs Twice-daily Cyclosporine in Dry Eye Disease","status":"COMPLETED","sponsor":"Korea University Anam Hospital","startDate":"2022-09-01","conditions":"Dry Eye Disease (DED)","enrollment":32},{"nctId":"NCT04781335","phase":"PHASE4","title":"\"A Prospective Study of the Efficacy of Intracameral Dexamethasone (Dexycu™) Compared to Standard of Care Treatment for Post-Cataract Surgical Pain and Anterior Chamber Inflammation\"","status":"COMPLETED","sponsor":"The Eye Institute of West Florida","startDate":"2020-02-20","conditions":"Cataract","enrollment":25},{"nctId":"NCT04097730","phase":"PHASE3","title":"Steroids and Cross-linking for Ulcer Treatment","status":"COMPLETED","sponsor":"Thomas M. Lietman","startDate":"2020-09-24","conditions":"Keratitis Bacterial","enrollment":280},{"nctId":"NCT06798025","phase":"NA","title":"Three Different Modalities for Treatment of Inflammatory Punctal Stenosis","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-07-20","conditions":"Modalities, Treatment, Inflammatory Punctal Stenosis","enrollment":60},{"nctId":"NCT06681688","phase":"PHASE1, PHASE2","title":"Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC","status":"RECRUITING","sponsor":"Inder Paul Singh, M.D.","startDate":"2024-07-10","conditions":"Cataract","enrollment":94},{"nctId":"NCT05158699","phase":"PHASE3","title":"Effectiveness of Periocular Drug Injection in CATaract Surgery","status":"TERMINATED","sponsor":"Luigi Rondas","startDate":"2021-10-13","conditions":"Macular Edema, Cystoid Macular Edema, Retinal Disease","enrollment":628},{"nctId":"NCT06643416","phase":"PHASE3","title":"Efficacy and Safety of Add-on Timolol for EGFR-TKI and ALK-TKI Induced Paronychia","status":"RECRUITING","sponsor":"Queen Mary Hospital, Hong Kong","startDate":"2024-10-09","conditions":"Paronychia, EGFR-TKI, ALK-TKI","enrollment":40},{"nctId":"NCT05724446","phase":"PHASE3","title":"Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population","status":"RECRUITING","sponsor":"Salvat","startDate":"2022-12-12","conditions":"Cataracts Infantile","enrollment":60},{"nctId":"NCT04396990","phase":"PHASE4","title":"The RESTORE Study, A Randomized, Controlled, Masked (Reading Center) Prospective Study","status":"COMPLETED","sponsor":"Vance Thompson Vision","startDate":"2020-06-08","conditions":"Refractive Surgery","enrollment":20},{"nctId":"NCT06498440","phase":"PHASE4","title":"Efficacy of NSAID vs. Steroid-NSAID Combo Post-Selective Laser Trabeculoplasty: Phase 4, Single-Center RCT","status":"NOT_YET_RECRUITING","sponsor":"St. Joseph's Healthcare Hamilton","startDate":"2024-09-01","conditions":"Open Angle Glaucoma, Ocular Hypertension, Postoperative Inflammation","enrollment":126},{"nctId":"NCT02120079","phase":"PHASE4","title":"The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DED","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2014-02","conditions":"Dry Eye Disease","enrollment":37},{"nctId":"NCT06404541","phase":"PHASE4","title":"A Comparative Study Between Preservative With Benzalkonium Chloride vs Preservative Free Eye Drops on the Ocular Surface","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kasr El Aini Hospital","startDate":"2024-01-10","conditions":"Ocular Surface Disease, Dry Eye Syndromes","enrollment":60},{"nctId":"NCT02528123","phase":"NA","title":"VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High Myopia","status":"COMPLETED","sponsor":"London Vision Clinic","startDate":"2016-04","conditions":"Myopia, Refractive Errors","enrollment":114},{"nctId":"NCT05633576","phase":"PHASE3","title":"Steroid Eye Drops in Chronic Central Serous Chorioretinopathy","status":"RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2023-02-19","conditions":"Chronic Central Serous Chorioretinopathy","enrollment":40},{"nctId":"NCT04707209","phase":"NA","title":"Sirolimus for Retinal Astrocytic Hamartoma","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2020-11-04","conditions":"Retinal Astrocytic Hamartoma","enrollment":1},{"nctId":"NCT03920007","phase":"PHASE1, PHASE2","title":"Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D","status":"ACTIVE_NOT_RECRUITING","sponsor":"Atsena Therapeutics Inc.","startDate":"2019-09-12","conditions":"Leber Congenital Amaurosis, LCA, LCA1","enrollment":15},{"nctId":"NCT06209879","phase":"PHASE4","title":"Dual-Polymer Hydroxypropyl Guar-and Hyaluronic Acid Lubricants in Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2024-02-05","conditions":"Dry Eye Syndromes","enrollment":40},{"nctId":"NCT04200651","phase":"PHASE4","title":"Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery","status":"TERMINATED","sponsor":"The New York Eye Surgery Center","startDate":"2020-01-13","conditions":"Glaucoma, Cataract","enrollment":25},{"nctId":"NCT01858922","phase":"PHASE2","title":"Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2012-12-19","conditions":"Hodgkin Disease","enrollment":40},{"nctId":"NCT06140186","phase":"PHASE3","title":"Efficacy and Safety of Timolol for TKI Induced Paronychia","status":"UNKNOWN","sponsor":"Queen Mary Hospital, Hong Kong","startDate":"2023-04-01","conditions":"Paronychia","enrollment":40},{"nctId":"NCT04184999","phase":"PHASE4","title":"Effect of Intraoperative Dexamethasone on Post-op Dry Eye","status":"COMPLETED","sponsor":"SR Cornea Consultants","startDate":"2019-08-10","conditions":"Dry Eye Syndromes","enrollment":40},{"nctId":"NCT04555694","phase":"PHASE4","title":"Comparing Treatment of Dry Eye With Intracanalicular Dexamethasone, Restasis, and/or Lotemax","status":"COMPLETED","sponsor":"Thomas Chester, OD","startDate":"2020-10-01","conditions":"Dry Eye","enrollment":30},{"nctId":"NCT05042609","phase":"PHASE3","title":"A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma","status":"COMPLETED","sponsor":"Tarsier Pharma","startDate":"2021-09-20","conditions":"Non-infectious Anterior Uveitis, Uveitic Glaucoma","enrollment":142},{"nctId":"NCT05973253","phase":"PHASE2, PHASE3","title":"Evaluation of Efficacy and Safety of Topical 1% Medroxyprogesterone in the Corneal Epithelium Healing After PRK","status":"COMPLETED","sponsor":"Isfahan University of Medical Sciences","startDate":"2023-04-21","conditions":"Photorefractive Keratectomy","enrollment":74},{"nctId":"NCT04521140","phase":"PHASE4","title":"Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery","status":"COMPLETED","sponsor":"Nicole Fram M.D.","startDate":"2020-10-16","conditions":"Corneal Edema, Corneal Defect, Corneal Transplant","enrollment":36},{"nctId":"NCT04462523","phase":"PHASE4","title":"DEXTENZA for the Treatment of Postoperative Pain and Inflammation Following Vitreo-retinal Surgery","status":"COMPLETED","sponsor":"Patrick R. Oellers, MD","startDate":"2020-01-03","conditions":"Vitreo-Retinal Surgery","enrollment":40},{"nctId":"NCT03634852","phase":"PHASE4","title":"A Two Chemoprophylaxis Approaches After Phacoemulsification Surgery","status":"COMPLETED","sponsor":"Suzan A Rattan","startDate":"2016-10-01","conditions":"Endophthalmitis Postoperative","enrollment":1000},{"nctId":"NCT04246801","phase":"PHASE3","title":"Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)","status":"COMPLETED","sponsor":"Salvat","startDate":"2020-06-10","conditions":"Cataract","enrollment":250},{"nctId":"NCT04249076","phase":"PHASE3","title":"Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)","status":"COMPLETED","sponsor":"Salvat","startDate":"2020-06-04","conditions":"Cataract","enrollment":215},{"nctId":"NCT04687800","phase":"PHASE4","title":"Clinical Investigation of the Dextenza 0.4mg Intracanalicular Insert Delivery System Used in Cataract Surgery","status":"TERMINATED","sponsor":"Cathleen McCabe MD","startDate":"2020-12-01","conditions":"Cataract","enrollment":1},{"nctId":"NCT04054830","phase":"PHASE4","title":"Steroids and/ or Non-steroidal Anti-inflammatory Drugs in the Postoperative Regime After Trabeculectomy.","status":"UNKNOWN","sponsor":"Rigshospitalet, Denmark","startDate":"2019-08-01","conditions":"Glaucoma","enrollment":70},{"nctId":"NCT05587231","phase":"PHASE4","title":"Comparison of the Postoperative Use of Dextenza vs a Standard Regimen After PRK","status":"UNKNOWN","sponsor":"Navy Medical Center San Diego","startDate":"2022-10","conditions":"Steroid Ophthalmic Insert","enrollment":60},{"nctId":"NCT03320434","phase":"PHASE2","title":"Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis","status":"COMPLETED","sponsor":"ORA, Inc.","startDate":"2017-10-13","conditions":"Allergic Conjunctivitis","enrollment":120},{"nctId":"NCT02873806","phase":"PHASE4","title":"Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive Agents","status":"COMPLETED","sponsor":"Glaukos Corporation","startDate":"2013-03","conditions":"Open-angle Glaucoma","enrollment":53},{"nctId":"NCT05314621","phase":"PHASE4","title":"A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Andover Research Eye Institute","startDate":"2021-12-31","conditions":"Allergic Conjunctivitis","enrollment":61},{"nctId":"NCT05248139","phase":"NA","title":"Safety and Effectiveness of Drop-free Small Incision Cataract Surgery","status":"UNKNOWN","sponsor":"Visualiza","startDate":"2022-10","conditions":"Cataract, Ocular Inflammation, Ocular Hypertension","enrollment":100},{"nctId":"NCT02688309","phase":"","title":"Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases","status":"TERMINATED","sponsor":"Johns Hopkins University","startDate":"2015-01-13","conditions":"Macular Edema, Fibrosis of the Retina","enrollment":44},{"nctId":"NCT05425914","phase":"PHASE3","title":"Impact of Vitamin D3 Supplementation in Non-Sjogren Dry Eye Patients With Low Serum Vitamin D Level","status":"COMPLETED","sponsor":"University of Faisalabad","startDate":"2021-11-01","conditions":"Dry Eye Syndromes, Hypovitaminosis D","enrollment":108},{"nctId":"NCT05318157","phase":"PHASE4","title":"Efficacy of Artemisia Pollen Specific Allergen Immunotherapy","status":"UNKNOWN","sponsor":"Beijing Tongren Hospital","startDate":"2022-03-31","conditions":"Allergic Rhinitis","enrollment":150},{"nctId":"NCT04940338","phase":"PHASE4","title":"PCME Prevention in Patients With NPDR","status":"COMPLETED","sponsor":"Klinički Bolnički Centar Zagreb","startDate":"2021-05-01","conditions":"Cystoid Macular Edema Following Cataract Surgery","enrollment":90},{"nctId":"NCT00061945","phase":"PHASE1, PHASE2","title":"Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2003-06","conditions":"Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia","enrollment":302},{"nctId":"NCT05353101","phase":"PHASE1","title":"Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis Trial","status":"COMPLETED","sponsor":"Second Affiliated Hospital of Nanchang University","startDate":"2020-07-01","conditions":"Vernal Keratoconjunctivitis, Cyclosporine 0.05% Eye Drops","enrollment":48},{"nctId":"NCT05350384","phase":"","title":"An Unusual Association Between Pancreatic Cancer and Purtscher-like Retinopathy","status":"COMPLETED","sponsor":"University of Catania","startDate":"2021-06-18","conditions":"Purtscher Retinopathy, Pancreatic Cancer","enrollment":1},{"nctId":"NCT02030990","phase":"PHASE2, PHASE3","title":"The Use of MMC During PRK and Its Effect on Postoperative Topical Steroid Requirements","status":"UNKNOWN","sponsor":"United States Naval Medical Center, San Diego","startDate":"2014-08","conditions":"Corneal Opacity","enrollment":300},{"nctId":"NCT04708821","phase":"PHASE4","title":"DEXTENZA Therapy for Treatment of Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Clinical Research Center of Florida","startDate":"2021-04-30","conditions":"Bilateral Conjunctivitis (Disorder)","enrollment":31},{"nctId":"NCT04005079","phase":"PHASE3","title":"Pilocarpine After Combined Cataract/Trabectome Surgery","status":"WITHDRAWN","sponsor":"Montefiore Medical Center","startDate":"2019-06-05","conditions":"Open Angle Glaucoma, Ocular Hypertension","enrollment":""},{"nctId":"NCT03626376","phase":"PHASE4","title":"Topical Corticosteroid Use in Addition to Oral Antivirals for Prevention of Recurrence of Herpes Simplex Virus (HSV) Keratitis","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2019-12-10","conditions":"Herpes Simplex Virus Keratitis","enrollment":""},{"nctId":"NCT01408082","phase":"PHASE3","title":"Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries Limited","startDate":"2011-10","conditions":"Blepharitis","enrollment":917},{"nctId":"NCT05116345","phase":"PHASE4","title":"DEXTENZA for the Treatment of Pain and Inflammation Following Surgical Trabeculectomy and Ahmed Valve Procedures","status":"UNKNOWN","sponsor":"Brian Jerkins, MD","startDate":"2021-11","conditions":"Glaucoma Following Surgery","enrollment":30},{"nctId":"NCT03640650","phase":"PHASE4","title":"Economic Impact of Dropless Therapy Versus Usual Care for Cataract Surgery: A Real-World Study.","status":"TERMINATED","sponsor":"PeriPharm","startDate":"2018-08-15","conditions":"Cataract Surgery","enrollment":80},{"nctId":"NCT03402802","phase":"","title":"Steroid Eyedrop Adherence After Trabeculectomy","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2019-09-01","conditions":"Glaucoma, Adherence, Patient","enrollment":92},{"nctId":"NCT04932629","phase":"EARLY_PHASE1","title":"To Evaluate the Clinical Safety and Efficacy of Limbal Stem Cell for Treatment of Superficial Corneal Pathologies\".","status":"UNKNOWN","sponsor":"L.V. Prasad Eye Institute","startDate":"2021-07","conditions":"Corneal Scars and Opacities","enrollment":20},{"nctId":"NCT03419403","phase":"PHASE3","title":"UNITE Study: Understanding New Interventions With GBM ThErapy","status":"TERMINATED","sponsor":"AbbVie","startDate":"2018-07-30","conditions":"Glioblastoma Multiforme","enrollment":40},{"nctId":"NCT04597762","phase":"NA","title":"Effect of Ciclosporin Eyedrops on Sjögren Syndrome","status":"COMPLETED","sponsor":"Hospital Hietzing","startDate":"2020-08-31","conditions":"Dry Eye Syndromes","enrollment":12},{"nctId":"NCT04711642","phase":"PHASE3","title":"Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery","status":"UNKNOWN","sponsor":"Fundación Oftalmológica Los Andes","startDate":"2021-01-15","conditions":"Dry Eye Disease, Dry Eye Syndrome, Evaporative Dry Eye","enrollment":100},{"nctId":"NCT04705584","phase":"NA","title":"Topical Immuonosuppressant Drugs in Spring Catarrh","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-01","conditions":"Vernal Keratoconjunctivitis","enrollment":180},{"nctId":"NCT02218489","phase":"PHASE2","title":"Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease","status":"COMPLETED","sponsor":"Kala Pharmaceuticals, Inc.","startDate":"2014-07","conditions":"Blepharitis","enrollment":206},{"nctId":"NCT03569995","phase":"PHASE2","title":"[CREMA]Combination of R-M Followed by R-A in Elderly Patients With Primary CNS Lymphoma","status":"UNKNOWN","sponsor":"Won Seog Kim","startDate":"2018-11-30","conditions":"Primary CNS Lymphoma","enrollment":35},{"nctId":"NCT02717871","phase":"PHASE3","title":"Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis","status":"COMPLETED","sponsor":"University Hospital, Geneva","startDate":"2016-03","conditions":"Keratitis; Infectious Disease (Manifestation)","enrollment":35},{"nctId":"NCT03672435","phase":"","title":"Strabismus Recovery With Proparacaine and Oculocardiac Reflex","status":"COMPLETED","sponsor":"Alaska Blind Child Discovery","startDate":"2010-07-29","conditions":"Strabismus, Bradycardia, Nausea","enrollment":140},{"nctId":"NCT02208297","phase":"PHASE3","title":"Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2014-09","conditions":"Inflammation, Pain, Cataract","enrollment":326},{"nctId":"NCT01996839","phase":"PHASE3","title":"Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2013-12","conditions":"Inflammation, Pain, Cataract","enrollment":514},{"nctId":"NCT04549935","phase":"PHASE4","title":"The PRIME Study: A Randomized, Controlled, Prospective Study","status":"RECRUITING","sponsor":"Vance Thompson Vision - MT","startDate":"2020-09-14","conditions":"Patient Preference, Patient Outcomes, Post-Operative Inflammation","enrollment":20},{"nctId":"NCT00689078","phase":"PHASE4","title":"Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model","status":"COMPLETED","sponsor":"ORA, Inc.","startDate":"2008-05","conditions":"Allergic Conjunctivitis","enrollment":36},{"nctId":"NCT03739528","phase":"PHASE3","title":"Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery","status":"COMPLETED","sponsor":"NTC srl","startDate":"2018-09-03","conditions":"Cataract","enrollment":808},{"nctId":"NCT03740659","phase":"PHASE2","title":"Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery","status":"COMPLETED","sponsor":"NTC srl","startDate":"2018-09-04","conditions":"Cataract","enrollment":125},{"nctId":"NCT04376970","phase":"PHASE4","title":"Treatment of Corneal Infiltrates Secondary to Epidemic Keratoconjunctivitis","status":"COMPLETED","sponsor":"Military Hospital of Tunis","startDate":"2017-04-01","conditions":"Adenoviral Keratoconjunctivitis","enrollment":51},{"nctId":"NCT04318652","phase":"PHASE4","title":"OCT Guided Punctal Stenosis Management","status":"COMPLETED","sponsor":"Tanta University","startDate":"2018-09-02","conditions":"Epiphora Due to Insufficient Drainage","enrollment":80},{"nctId":"NCT04281862","phase":"PHASE4","title":"DEXTENZA Compared to Topical Prednisolone in Patients Undergoing Bilateral LASIK Surgery","status":"UNKNOWN","sponsor":"Vance Thompson Vision","startDate":"2020-01-23","conditions":"Refractive Surgery","enrollment":20},{"nctId":"NCT01797822","phase":"PHASE4","title":"Effects of Dry Eye Treatments on the Ocular Surface","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2013-02","conditions":"Keratoconjunctivitis Sicca, Dry Eye Syndrome","enrollment":20},{"nctId":"NCT04153253","phase":"PHASE4","title":"Intravitreal Aflibercept Injection or Early Vitrectomy for Diabetic Vitreous Hemorrhage","status":"COMPLETED","sponsor":"Al Hadi Hospital","startDate":"2018-03-07","conditions":"Diabetic Vitreous Hemorrhage","enrollment":34},{"nctId":"NCT03383328","phase":"PHASE4","title":"Study for Optimizing Anti-inflammatory Prophylaxis","status":"COMPLETED","sponsor":"Line Kessel","startDate":"2018-02-01","conditions":"Postoperative Cystoid Macular Edema, Irvine-Gass Syndrome","enrollment":470},{"nctId":"NCT04205916","phase":"PHASE4","title":"A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery","status":"RECRUITING","sponsor":"Ophthalmic Consultants of Long Island","startDate":"2019-11-04","conditions":"Patient Preference","enrollment":50},{"nctId":"NCT03693989","phase":"PHASE3","title":"Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for Inflammation and Pain After Phacoemulsification","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2018-10-04","conditions":"Cataract","enrollment":178}],"_emaApprovals":[],"_faersSignals":[{"count":4,"reaction":"INJECTION SITE PAIN"},{"count":4,"reaction":"INSOMNIA"},{"count":3,"reaction":"CONDITION AGGRAVATED"},{"count":3,"reaction":"OCULAR HYPERAEMIA"},{"count":3,"reaction":"PAIN"},{"count":2,"reaction":"AUTOIMMUNE DISORDER"},{"count":2,"reaction":"DELUSION"},{"count":2,"reaction":"DRUG INEFFECTIVE"},{"count":2,"reaction":"ERYTHEMA"},{"count":2,"reaction":"FLUSHING"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"steroid eye drops","genericName":"steroid eye drops","companyName":"Radboud University Medical Center","companyId":"radboud-university-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Steroid eye drops, specifically triamcinolone acetonide, are used to treat conditions such as allergic conjunctivitis, vernal keratoconjunctivitis, and inflammatory punctal stenosis. Triamcinolone acetonide is a small molecule that works as a topical medication, often used in conjunction with punctal dilation to treat these conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}